152 related articles for article (PubMed ID: 27056200)
1. Clinicopathological characteristics and outcomes of light chain deposition disease: an analysis of 48 patients in a single Chinese center.
Li XM; Rui HC; Liang DD; Xu F; Liang SS; Zhu XD; Huang XH; Liu ZH; Zeng CH
Ann Hematol; 2016 May; 95(6):901-9. PubMed ID: 27056200
[TBL] [Abstract][Full Text] [Related]
2. Heavy Chain Deposition Disease: Clinicopathologic Characteristics of a Chinese Case Series.
Zhang Y; Li X; Liang D; Xu F; Liang S; Zhu X; Zheng N; Huang X; Liu Z; Zeng C
Am J Kidney Dis; 2020 May; 75(5):736-743. PubMed ID: 31699519
[TBL] [Abstract][Full Text] [Related]
3. Renal monoclonal immunoglobulin deposition disease: the disease spectrum.
Lin J; Markowitz GS; Valeri AM; Kambham N; Sherman WH; Appel GB; D'Agati VD
J Am Soc Nephrol; 2001 Jul; 12(7):1482-1492. PubMed ID: 11423577
[TBL] [Abstract][Full Text] [Related]
4. Light chain deposition disease without glomerular proteinuria: a diagnostic challenge for the nephrologist.
Sicard A; Karras A; Goujon JM; Sirac C; Bender S; Labatut D; Callard P; Sarkozy C; Essig M; Vanhille P; Provot F; Nony A; Nochy D; Ronco P; Bridoux F; Touchard G
Nephrol Dial Transplant; 2014 Oct; 29(10):1894-902. PubMed ID: 24619059
[TBL] [Abstract][Full Text] [Related]
5. Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution.
Nasr SH; Valeri AM; Cornell LD; Fidler ME; Sethi S; D'Agati VD; Leung N
Clin J Am Soc Nephrol; 2012 Feb; 7(2):231-9. PubMed ID: 22156754
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of renal transplantation in light-chain deposition disease.
Leung N; Lager DJ; Gertz MA; Wilson K; Kanakiriya S; Fervenza FC
Am J Kidney Dis; 2004 Jan; 43(1):147-53. PubMed ID: 14712438
[TBL] [Abstract][Full Text] [Related]
7. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological Characteristics of Light and Heavy Chain Deposition Disease: A Case Series.
Wang Y; Chen D; Hu R; Zhang Y; Liang D; Xu F; Liu F; Zhu X; Lin Y; Yang X; Liu X; Xing G; Liang S; Zeng C
Am J Kidney Dis; 2024 May; ():. PubMed ID: 38750878
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features and prognosis in immunoglobulin light and heavy chain deposition disease.
Masai R; Wakui H; Togashi M; Maki N; Ohtani H; Komatsuda A; Sawada K
Clin Nephrol; 2009 Jan; 71(1):9-20. PubMed ID: 19203545
[TBL] [Abstract][Full Text] [Related]
10. Clinic-pathological characteristics of rare tubulointerstitial diseases.
Shi K; Yuan S; Huang Y; Li Z; Wang C; Liu H; Sun L; Liu F; Zhu X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 47(10):1365-1374. PubMed ID: 36411687
[TBL] [Abstract][Full Text] [Related]
11. Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors.
Pozzi C; D'Amico M; Fogazzi GB; Curioni S; Ferrario F; Pasquali S; Quattrocchio G; Rollino C; Segagni S; Locatelli F
Am J Kidney Dis; 2003 Dec; 42(6):1154-63. PubMed ID: 14655186
[TBL] [Abstract][Full Text] [Related]
12. Light chain deposition disease without detectable light chains in serum or urine. Report of a case and review of the literature.
van Ingen G; van Bronswijk H; Meijer CJ; Stel HV
Neth J Med; 1991 Oct; 39(3-4):142-7. PubMed ID: 1791875
[TBL] [Abstract][Full Text] [Related]
13. The characteristics of patients with kidney light chain deposition disease concurrent with light chain amyloidosis.
Said SM; Best Rocha A; Valeri AM; Paueksakon P; Dasari S; Theis JD; Vrana JA; Obadina MO; Saghafi D; Alexander MP; Sethi S; Larsen CP; Joly F; Dispenzieri A; Bridoux F; Sirac C; Leung N; Fogo AB; McPhail ED; Nasr SH
Kidney Int; 2022 Jan; 101(1):152-163. PubMed ID: 34767832
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of autologous stem cell transplantation in light chain deposition disease.
Lorenz EC; Gertz MA; Fervenza FC; Dispenzieri A; Lacy MQ; Hayman SR; Gastineau DA; Leung N
Nephrol Dial Transplant; 2008 Jun; 23(6):2052-7. PubMed ID: 18178602
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease.
Mohan M; Buros A; Mathur P; Gokden N; Singh M; Susanibar S; Jo Kamimoto J; Hoque S; Radhakrishnan M; Matin A; Davis C; Grazziutti M; Thanendrarajan S; van Rhee F; Zangari M; Davies F; Morgan G; Epstein J; Barlogie B; Schinke C
Am J Hematol; 2017 Aug; 92(8):739-745. PubMed ID: 28383130
[TBL] [Abstract][Full Text] [Related]
16. Clinical and prognostic differences among patients with light chain deposition disease, myeloma cast nephropathy and both.
Zand L; Nasr SH; Gertz MA; Dispenzieri A; Lacy MQ; Buadi FK; Kumar S; Kyle RA; Fervenza FC; Sethi S; Dingli D; Rajkumar SV; Kapoor P; McCurdy A; Leung N
Leuk Lymphoma; 2015; 56(12):3357-64. PubMed ID: 25860232
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological features and outcomes of coexistent light chain cast nephropathy and light chain deposition disease in patients with newly diagnosed multiple myeloma.
Lin ZS; Zhang X; Li DY; Yu XJ; Qin AB; Dong Y; Zhou FD; Wang S; Zhao MH
J Clin Pathol; 2021 Jun; ():. PubMed ID: 34187849
[TBL] [Abstract][Full Text] [Related]
18. Trends in Survival and Renal Recovery in Patients with Multiple Myeloma or Light-Chain Amyloidosis on Chronic Dialysis.
Decourt A; Gondouin B; Delaroziere JC; Brunet P; Sallée M; Burtey S; Dussol B; Ivanov V; Costello R; Couchoud C; Jourde-Chiche N
Clin J Am Soc Nephrol; 2016 Mar; 11(3):431-41. PubMed ID: 26728585
[TBL] [Abstract][Full Text] [Related]
19. Kidney and liver involvement in monoclonal light chain disorders.
Pozzi C; Locatelli F
Semin Nephrol; 2002 Jul; 22(4):319-30. PubMed ID: 12118397
[TBL] [Abstract][Full Text] [Related]
20. Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management.
Bridoux F; Javaugue V; Bender S; Leroy F; Aucouturier P; Debiais-Delpech C; Goujon JM; Quellard N; Bonaud A; Clavel M; Trouillas P; Di Meo F; Gombert JM; Fermand JP; Jaccard A; Cogné M; Touchard G; Sirac C
Kidney Int; 2017 Feb; 91(2):423-434. PubMed ID: 27773425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
